Bipartisan cannabis banking bill clears U.S. House
Key Takeaways
On April 19, the U.S. House of Representatives passed the Secure and Fair Enforcement (SAFE) Banking Act of 2021 (H.R. 1996) on a bipartisan vote of 321-101. The bill would shield banks and insurers from federal penalties if they choose to provide services to legitimate cannabis-related businesses.
To date, 47 states and the District of Columbia have legalized some form of cannabis for recreational and/or medicinal purposes, including CBD. This federal legislation would provide relief to what is currently a predominantly cash-only industry, which makes businesses vulnerable to robberies and other crimes, by providing access to checking accounts, loans and other banking services.
The bill now heads to the Senate, where Senate Majority Leader Chuck Schumer (D-N.Y.) has indicated his support for the legislation. However, the Majority Leader has said he would prefer to move the measure as part of a more-comprehensive criminal justice reform package, which could complicate the outlook for passage.
NACo supports legislation that would ensure greater access to banking for legally sanctioned commercial cannabis activities and will continue to monitor this legislation as it moves through Congress.
Advocacy
Cannabis reform included as part of criminal justice bill introduced by Sen. Booker
Related News
FEMA releases nearly $1 billion in preparedness grants
On August 1, the Federal Emergency Management Agency (FEMA) announced nearly $1 billion in new grant funding to help states, local governments, tribes and territories strengthen disaster preparedness.
HALT Fentanyl Act signed into law
On July 16, the Halt All Lethal Trafficking of Fentanyl Act (HALT Fentanyl Act) (P.L. 119-26) was signed into law, marking a major turning point in the nation’s response to the opioid epidemic. The bipartisan legislation permanently classifies fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act, granting law enforcement the authority to combat the growing threat posed by synthetic opioids. The law’s enactment follows years of temporary extensions that placed these substances under federal control on a provisional basis.
